g

or
a.
on
el
rc
The need of a third trimester screening

ba
al
Impact on fetal programming

et
af
in
Fatima Crispi, Eduard Gratacos
ic
ed

Maternal-Fetal Medicine Department and Research Center

.m

Hospital Clinic - University of Barcelona

w
w

www.medicinafetalbarcelona.org
w
©
 g
or
a.
on
el
FIRST TRIMESTER ?

rc
ba
screening of major

al
et
pregnancy complications
af
in
ic
ed
.m
w
w
w
©

Down’s structural preeclampsia prematurity

syndrome malformations IUGR
 screening for PE/IUGR

11-14 wks early late

g
PE/IUGR PE/IUGR

or
a.
on
el
COMBINED 1T SCREENING

rc
ba
al
et
?
af
in
ic
ed

milder disease
.m

heterogeneity
w

highly predictive for limited for (+/- placental disease)

w
w

EARLY PE/IUGR LATE PE/IUGR

©

DR 60-90% DR 20-60%
(PFR 10%) (FPR 10%)

Crispi UOG 2007, Poon Hypertens 209, Scazzochio AJOG 2013, Crovetto UOG 2013
 prediction of PE & IUGR
EARLY-ONSET LATE-ONSET

g
or
a.
on
IMPORTANCE OF LATE PE/IUGR

el
4-8 %

rc
PREECLAMPSIA

ba
1%
high prevalence

al
et
PREECLAMPSIA + IUGR

af
maternal
1% serious complications
cause of stillbirth in IUGR
ic
4-8 %
ed

fetal programming
.m
w
w
w

20 25 30 35 40
©

www.fetalmedicinebarcelona.org/
Late-onset IUGR (>34w + normal UA Doppler)

g
or
adverse perinatal outcome in 376 consecutive cases

a.
on
el
rc
ba
al
et
af
in
ic
ed
.m
w
w
w
©

Figueras 2011
 Biological programming and age

g
or
a.
on
el
rc
ba
al
et
af
in
ic
ed
IMPACT OF
ENVIRONMENT
.m

epigenetics
w
w

Fetus Child Young Mature Old

w
©

FETAL
PROGRAMMING
 1986 Barker (MRC Unit, Southampton, UK):
Coronary heart disease mortality rates

g
or
a.
on
el
rc
ba
al
et
af
in
ic
ed
.m
w
w
w
©
 FETAL CARDIOVASCULAR PROGRAMMING

g
PRIMARY

or
intrauterine CARDIOVASCULAR

a.
growth PROGRAMMING cardiovascular

on
restriction disease in

el
fetal cardiac adulthood

rc
dysfunction hypertension

ba
coronary disease

al
stroke

et
obesity

af
diabetes
in
ic
ed

impact of mild
.m

late IUGR / SGA

w
w
w
©

Barker BMJ 1986, Barker BMJ 1995 , Hecher Circulation 1995, Crispi AJOG 2008, Crispi Circulation 2010, Cruz FDT 2011, Crispi AJOG 2012
 Exposure
Prematurity Infection

g
or
Fetal growth restriction Genetics

a.
on
el
Neurocognitive disorders/Learning disabilities

rc
Overall ≥10%

ba
Estimated 2/3 of prenatal origin

al
et
Non-specific disorders
5-8%

af
Attention Deficit Hyperactivity
in Autism Spectrum Disorder
ic
Disorder 0.5-1%
ed
2-5%
.m

120
* * *
w

100
w Bayley Score

impact of mild 80
w

late IUGR / SGA 60

Satchev, 2012
©

40
Figueras 2006-2011
Baschat 2009, 2011
20 Vohr 2004
Geva 2002-2011
Marsal 00-06
cognitive language motor socio-emot adaptive Visser 01-11
behavior
 fetal programming

g
or
placental

a.
coronary disease

on
disease
hypertension
prematurity

el
obesity
infection

rc
diabetes
IVF

ba
atention disorders
twins
autism spectrum

al
et
IMPACT OF

af
ENVIRONMENT

in
ic
OPPORTUNITY
ed

FOR
.m

CORRECTION
w
w

Fetus Child Young Mature Old

w
©
 g
4P medicine

or
•Predictive
•Preventive

a.
•Personalized

on
•Participatory
IDENTIFICATION OF RISK

el
rc
INDIVIDUAL

ba
BIOMARKERS

al
et
INTERVENTION

af
in
ic
WINDOW OF
ed

OPPORTUNITY
w BIRTH
.m
w

Fetus Child
w

Functional / structural
©

Problem evident
organ remodeling
 screening for late PE

g
or
32-34w

a.
PE

on
el
rc
THIRD TRIMESTER APPROACH

ba
maternal OR UtA Doppler OR biomarkers

al
et
af
in
ic
ed
.m

Detection Rates (for FPR 10%)

w
w

Lai et al. Fetal Diagn Ther 2013

LATE PE
w

(BP, UtA Doppler, sEng)

©

Chaiworapongsa et al. AJOG 2013

(PlGF, sFlt-1, sEng) 70-75 %

www.medicinafetalbarcelona.org/
 screening for late IUGR
IMPROVING DETECTION: THE DEFINITION OF “RESTRICTION”

g
or
a.
on
el
rc
ba
al
et
af
in
ic
ed
.m
w
w
w
©
 screening for late IUGR
IMPROVING DETECTION: THE DEFINITION OF “RESTRICTION”

g
Birthweight inverse relation with perinatal outcome AND brain-cardiac remodelling

or
a.
on
el
rc
ba
al
et
af
in
ic
ed
.m
w
w
w

INTEGRATED 3T SCREENING FOR LATE-PREGNANCY COMPLICATIONS

©

Late-PE, Late-IUGR, Stillbirth

Mula 2012
 g
or
4P (fetal) medicine
INTEGRATED THIRD TRIMESTER

a.
SCREENING FOR THE PREDICTION OF

on
PERINATAL AND LONG-TERM OUTCOME

el
rc
IDENTIFICATION OF RISK

ba
INDIVIDUAL

al
BIOMARKERS

et
af
INTERVENTION

in
ic
WINDOW OF
ed

OPPORTUNITY
wBIRTH
.m
w

Fetus Child
w
©

Functional / structural
Problem evident
organ remodeling
thank you
fcrispi@clinic.ub.es gratacos@clinic.ub.es
 g
or
a.
on
el
rc
towards integrated third trimester

ba
al
screening in pregnancy

et
af
in
ic
ed
.m
w
w
w

thank you
©

fcrispi@clinic.ub.es
gratacos@clinic.ub.es